|MyoKardia Inc -- USA Stock|| |
USD 50.50 1.85 3.80%
We currently do not have informatin regarding Leslie Leinwand. This executive tanure with MyoKardia Inc is not currenlty determined.
The company has return on total asset (ROA)
of (12.29) %
which means that it has lost $12.29 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (23.74) %
meaning that it created substantial loss on money invested by shareholders.
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of rare cardiovascular diseases. MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California. MyoKardia is traded on NASDAQ in USA.MyoKardia Inc (MYOK) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 102 people. MyoKardia is listed under Pharmaceutical Products category by Fama And French industry classification.